Plasma biomarkers of lower gastrointestinal and liver acute GVHD

Andrew C. Harris, James L M Ferrara, Thomas M. Braun, Ernst Holler, Takanori Teshima, John E. Levine, Sung W. Choi, Karin Landfried, Koichi Akashi, Mark Vander Lugt, Daniel R. Couriel, Pavan Reddy, Sophie Paczesny

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

The lower gastrointestinal tract (LGI) and liver are the GVHD target organs most associated with treatment failure and nonrelapse mortality. We recently identified regenerating islet-derived 3-α (REG3α) as a plasma biomarker of LGI GVHD. We compared REG3α with 2 previously reported GI and liver GVHD diagnostic biomarkers, hepatocyte growth factor (HGF) and cytokeratin fragment 18, in 954 hematopoietic cell transplantation patients. All 3 biomarkers were significantly elevated in LGI GVHD compared with non-GVHD diarrhea; REG3α discerned LGI GVHD from non-GVHD diarrhea better than HGF and cytokeratin fragment 18. Although all 3 biomarkers predicted nonresponse to therapy at day 28 in LGI GVHD patients, only REG3α and HGF concentrations predicted 1-year nonrelapse mortality (P = .01 and P = .02, respectively). Liver GVHD without GI involvement at GVHD onset and non-GVHD liver complications were uncommon; all 3 biomarkers were elevated in liver GVHD, but did not distinguish GVHD from other causes of hyperbilirubinemia.

Original languageEnglish (US)
Pages (from-to)2960-2963
Number of pages4
JournalBlood
Volume119
Issue number12
DOIs
StatePublished - Mar 22 2012
Externally publishedYes

Fingerprint

Lower Gastrointestinal Tract
Biomarkers
Liver
Hepatocyte Growth Factor
Plasmas
Keratin-18
Keratins
Diarrhea
Hyperbilirubinemia
Mortality
Cell Transplantation
Treatment Failure

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Harris, A. C., Ferrara, J. L. M., Braun, T. M., Holler, E., Teshima, T., Levine, J. E., ... Paczesny, S. (2012). Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood, 119(12), 2960-2963. https://doi.org/10.1182/blood-2011-10-387357

Plasma biomarkers of lower gastrointestinal and liver acute GVHD. / Harris, Andrew C.; Ferrara, James L M; Braun, Thomas M.; Holler, Ernst; Teshima, Takanori; Levine, John E.; Choi, Sung W.; Landfried, Karin; Akashi, Koichi; Lugt, Mark Vander; Couriel, Daniel R.; Reddy, Pavan; Paczesny, Sophie.

In: Blood, Vol. 119, No. 12, 22.03.2012, p. 2960-2963.

Research output: Contribution to journalArticle

Harris, AC, Ferrara, JLM, Braun, TM, Holler, E, Teshima, T, Levine, JE, Choi, SW, Landfried, K, Akashi, K, Lugt, MV, Couriel, DR, Reddy, P & Paczesny, S 2012, 'Plasma biomarkers of lower gastrointestinal and liver acute GVHD', Blood, vol. 119, no. 12, pp. 2960-2963. https://doi.org/10.1182/blood-2011-10-387357
Harris AC, Ferrara JLM, Braun TM, Holler E, Teshima T, Levine JE et al. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood. 2012 Mar 22;119(12):2960-2963. https://doi.org/10.1182/blood-2011-10-387357
Harris, Andrew C. ; Ferrara, James L M ; Braun, Thomas M. ; Holler, Ernst ; Teshima, Takanori ; Levine, John E. ; Choi, Sung W. ; Landfried, Karin ; Akashi, Koichi ; Lugt, Mark Vander ; Couriel, Daniel R. ; Reddy, Pavan ; Paczesny, Sophie. / Plasma biomarkers of lower gastrointestinal and liver acute GVHD. In: Blood. 2012 ; Vol. 119, No. 12. pp. 2960-2963.
@article{adab776c856b4d03899b9fc5c14e7e4e,
title = "Plasma biomarkers of lower gastrointestinal and liver acute GVHD",
abstract = "The lower gastrointestinal tract (LGI) and liver are the GVHD target organs most associated with treatment failure and nonrelapse mortality. We recently identified regenerating islet-derived 3-α (REG3α) as a plasma biomarker of LGI GVHD. We compared REG3α with 2 previously reported GI and liver GVHD diagnostic biomarkers, hepatocyte growth factor (HGF) and cytokeratin fragment 18, in 954 hematopoietic cell transplantation patients. All 3 biomarkers were significantly elevated in LGI GVHD compared with non-GVHD diarrhea; REG3α discerned LGI GVHD from non-GVHD diarrhea better than HGF and cytokeratin fragment 18. Although all 3 biomarkers predicted nonresponse to therapy at day 28 in LGI GVHD patients, only REG3α and HGF concentrations predicted 1-year nonrelapse mortality (P = .01 and P = .02, respectively). Liver GVHD without GI involvement at GVHD onset and non-GVHD liver complications were uncommon; all 3 biomarkers were elevated in liver GVHD, but did not distinguish GVHD from other causes of hyperbilirubinemia.",
author = "Harris, {Andrew C.} and Ferrara, {James L M} and Braun, {Thomas M.} and Ernst Holler and Takanori Teshima and Levine, {John E.} and Choi, {Sung W.} and Karin Landfried and Koichi Akashi and Lugt, {Mark Vander} and Couriel, {Daniel R.} and Pavan Reddy and Sophie Paczesny",
year = "2012",
month = "3",
day = "22",
doi = "10.1182/blood-2011-10-387357",
language = "English (US)",
volume = "119",
pages = "2960--2963",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Plasma biomarkers of lower gastrointestinal and liver acute GVHD

AU - Harris, Andrew C.

AU - Ferrara, James L M

AU - Braun, Thomas M.

AU - Holler, Ernst

AU - Teshima, Takanori

AU - Levine, John E.

AU - Choi, Sung W.

AU - Landfried, Karin

AU - Akashi, Koichi

AU - Lugt, Mark Vander

AU - Couriel, Daniel R.

AU - Reddy, Pavan

AU - Paczesny, Sophie

PY - 2012/3/22

Y1 - 2012/3/22

N2 - The lower gastrointestinal tract (LGI) and liver are the GVHD target organs most associated with treatment failure and nonrelapse mortality. We recently identified regenerating islet-derived 3-α (REG3α) as a plasma biomarker of LGI GVHD. We compared REG3α with 2 previously reported GI and liver GVHD diagnostic biomarkers, hepatocyte growth factor (HGF) and cytokeratin fragment 18, in 954 hematopoietic cell transplantation patients. All 3 biomarkers were significantly elevated in LGI GVHD compared with non-GVHD diarrhea; REG3α discerned LGI GVHD from non-GVHD diarrhea better than HGF and cytokeratin fragment 18. Although all 3 biomarkers predicted nonresponse to therapy at day 28 in LGI GVHD patients, only REG3α and HGF concentrations predicted 1-year nonrelapse mortality (P = .01 and P = .02, respectively). Liver GVHD without GI involvement at GVHD onset and non-GVHD liver complications were uncommon; all 3 biomarkers were elevated in liver GVHD, but did not distinguish GVHD from other causes of hyperbilirubinemia.

AB - The lower gastrointestinal tract (LGI) and liver are the GVHD target organs most associated with treatment failure and nonrelapse mortality. We recently identified regenerating islet-derived 3-α (REG3α) as a plasma biomarker of LGI GVHD. We compared REG3α with 2 previously reported GI and liver GVHD diagnostic biomarkers, hepatocyte growth factor (HGF) and cytokeratin fragment 18, in 954 hematopoietic cell transplantation patients. All 3 biomarkers were significantly elevated in LGI GVHD compared with non-GVHD diarrhea; REG3α discerned LGI GVHD from non-GVHD diarrhea better than HGF and cytokeratin fragment 18. Although all 3 biomarkers predicted nonresponse to therapy at day 28 in LGI GVHD patients, only REG3α and HGF concentrations predicted 1-year nonrelapse mortality (P = .01 and P = .02, respectively). Liver GVHD without GI involvement at GVHD onset and non-GVHD liver complications were uncommon; all 3 biomarkers were elevated in liver GVHD, but did not distinguish GVHD from other causes of hyperbilirubinemia.

UR - http://www.scopus.com/inward/record.url?scp=84863371821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863371821&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-10-387357

DO - 10.1182/blood-2011-10-387357

M3 - Article

VL - 119

SP - 2960

EP - 2963

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -